SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 155 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,404 | -44.7% | 32,350 | +19.8% | 0.00% | – |
| Q2 2023 | $35,100 | -41.7% | 27,000 | -21.1% | 0.00% | – |
| Q1 2023 | $60,192 | -29.2% | 34,200 | +26.3% | 0.00% | – |
| Q4 2022 | $85,034 | -35.6% | 27,081 | +0.3% | 0.00% | – |
| Q3 2022 | $132,000 | -98.3% | 27,000 | -96.2% | 0.00% | -100.0% |
| Q2 2015 | $7,944,000 | -29.3% | 716,300 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $11,232,000 | +3.1% | 716,300 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $10,895,000 | +31.2% | 716,300 | -6.9% | 0.01% | +25.0% |
| Q3 2014 | $8,302,000 | -43.1% | 769,800 | -19.4% | 0.00% | -33.3% |
| Q2 2014 | $14,589,000 | -26.4% | 955,400 | -12.8% | 0.01% | -33.3% |
| Q1 2014 | $19,817,000 | – | 1,096,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 916,153 | $8,740,000 | 1.27% |
| Casdin Capital, LLC | 1,080,000 | $10,303,000 | 1.13% |
| Rhenman & Partners Asset Management AB | 843,957 | $8,051,000 | 0.94% |
| WASATCH ADVISORS LP | 6,437,908 | $61,418,000 | 0.67% |
| BB BIOTECH AG | 2,650,000 | $25,281,000 | 0.64% |
| Trellus Management Company, LLC | 30,000 | $286,000 | 0.54% |
| Opus Point Partners Management, LLC | 33,529 | $320,000 | 0.43% |
| SECTOR GAMMA AS | 238,857 | $2,279,000 | 0.36% |
| Leisure Capital Management | 37,656 | $359,000 | 0.30% |
| Ceeto Capital Group, LLC | 41,000 | $391,000 | 0.29% |